Table 1: Baseline data obtained from the intention-to-treat patients in the experimental (TZD + EA) and placebo groups (TZD).

GroupsTZD + EA ( )TZD ( ) -Value

Age (Years) 0.74 (NS)
Body Height (cm) 0.27 (NS)
Body Weight (Kg) 0.54 (NS)
BMI (Kg/m2) 0.93 (NS)
Glucose (mmol/L) 0.51 (NS)
HbA1C (%) 1.00 (NS)
Cr (μmol/L) 0.20 (NS)
GPT (IU/L) 0.71 (NS)
Cholesterol (mmol/L) 0.44 (NS)
Triglyceride (mmol/L) 0.81 (NS)
Take OHA (Yes : No)10 : 610 : 50.91 (NS)

All values are shown as mean ± SEM except for the use of oral hypoglycemic agents (OHA); TZD + EA = experimental group, who were patients that received 8 mg rosiglitazone and electroacupuncture; TZD = placebo group, who were patients that received 8 mg rosiglitazone only. Independent groups were compared using the nonparametric Mann-Whitney test. NS, means no significant difference, .